A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

NCT00055250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: LY293111
DRUG: placebo

Sponsor

Eli Lilly and Company